Atlas Trials

Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency

Clinical trial NCT07502378 · RECRUITING

Trial details

NCT number
NCT07502378
Sponsor
University of South Florida
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Ocular Surface DiseaseNeurotrophic Keratopathy Stage 1
Start date
2026-04-06
Primary completion
2027-03-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.